[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"trial:NCT05314426":3,"trial-entities:NCT05314426":75,"trial-summary:NCT05314426":79},{"id":4,"nct_id":4,"org_study_id":5,"brief_title":6,"official_title":6,"overall_status":7,"completion_date":8,"status_verified_date":9,"last_update_date":10,"start_date":11,"sponsor_name":12,"lead_sponsor_class":13,"has_dmc":14,"brief_summary":15,"detailed_description":16,"conditions":17,"keywords":19,"study_type":20,"primary_purpose":16,"phases":21,"enrollment_info":22,"interventions":25,"primary_outcomes":26,"secondary_outcomes":40,"sex":41,"minimum_age":42,"maximum_age":16,"healthy_volunteers":14,"eligibility_criteria":43,"std_ages":52,"locations":55,"central_contacts":65,"overall_officials":66,"references":70,"see_also_links":71},"NCT05314426","21-013112","Mayo Clinic Phage Program Biobank","ENROLLING_BY_INVITATION","2027-04","2026-06","2026-06-24","2022-04-19","Mayo Clinic","OTHER",false,"The purpose of this study is to help scientists and clinicians discover answers to research questions related to antibiotic-resistant bacterial infections, and the role that phage therapy plays as a possible treatment.",null,[18],"Bacteriophage Therapy",[],"OBSERVATIONAL",[],{"count":23,"type":24},100,"ESTIMATED",[],[27,31,34,37],{"measure":28,"description":29,"timeFrame":30},"Enrollment of study participants","To recruit and enroll participants up to 100 participants who have received or will receive phage therapy treatment","5 years",{"measure":32,"description":33,"timeFrame":30},"Collection of biospecimens","Total number of biospecimens collected which may include blood samples and synovial fluid",{"measure":35,"description":36,"timeFrame":30},"Medical record review","Review the medical record of enrolled participants to ascertain any new health outcomes.",{"measure":38,"description":39,"timeFrame":30},"Increase treatment options and level of care for patients with bacterial infections","Total number of collaborations with clinical investigators and researchers at both Mayo Clinic and across the globe.",[],"ALL","18 Years",{"inclusion":44,"exclusion":48,"raw_text":51},[45,46,47],"≥ 18 years of age.","Able to provide informed consent.","Individual must have a future treatment plan to receive or has historically received phage therapy.",[49,50],"Individuals , 18 years of age.","Unwilling\u002Funable to provide informed consent.","Inclusion Criteria:\n\n* ≥ 18 years of age.\n* Able to provide informed consent.\n* Individual must have a future treatment plan to receive or has historically received phage therapy.\n\nExclusion Criteria:\n\n* Individuals , 18 years of age.\n* Unwilling\u002Funable to provide informed consent.",[53,54],"ADULT","OLDER_ADULT",[56],{"facility":57,"city":58,"state":59,"zip":60,"country":61,"geoPoint":62},"Mayo Clinic Rochester","Rochester","Minnesota","55905","United States",{"lat":63,"lon":64},44.02163,-92.4699,[],[67],{"name":68,"affiliation":12,"role":69},"Gina Suh, MD","PRINCIPAL_INVESTIGATOR",[],[72],{"label":73,"url":74},"Mayo Clinic Clinical Trials","https:\u002F\u002Fwww.mayo.edu\u002Fresearch\u002Fclinical-trials",{"nct_id":4,"conditions":76,"biomarkers":78},[77],"Bacterial Infection",[],{"nct_id":4,"found":14,"summary":16,"prompt_version":16}]